Back in June 2019, we attended the International Society for Stem Cell Research’s (ISSCR) annual conference in Los Angeles, California! Here is the second of three special episodes featuring interviews with some of the top researchers in the stem cell field, as well as with up-and-coming junior trainees who talked to Daylon about their research and experience at the conference.
We asked Junior Trainees the following question:
WHAT IS THE GREATEST CHALLENGE CURRENTLY FACING THE STEM CELL RESEARCH FIELD?
Ojeni Touma; Intern, California Institute for Regenerative Medicine
Oriana Genolet; Graduate Student, Max Planck Institute
Alejandro Torres; Graduate Student, University of California, Los Angeles
Vivian Lu; Graduate Student, University of California, Los Angeles
Aaron Sandoval; Undergraduate Student, University of Florida
Sanjay Kumar; Scientist, Christian Medical College, India
Ana Rita Leitoguinho; Graduate Student, Murdoch Children’s Research Institute
Namisha Mazumdar; Undergraduate Student, University of Southern California
Dr. Leonard Zon, MD; Principal Investigator, Harvard Department of Stem Cell and Regenerative Biology
Dr. Leonard Zon is the founder of the International Society of Stem Cell Research, and is a pioneer in the fields of stem cell biology and cancer genetics. His lab uses the zebrafish model for researching hematopoiesis, and to screen for oncogenes and proteins.
Dr. Ting Chen, PhD; Assistant Investigator, National Institute of Biological Sciences, Beijing
Dr. Ting Chen studies epithelial regeneration, using mice as a genetic model. Her lab focuses on stem cell self-renewal mechanisms and fate specification.
Dr. Dieter Egli, PhD; Assistant Professor, Columbia University
Before iPSC technology, Dr. Egli used somatic cell nuclear transfer on human cells to generate stem cells. His current work focuses on deriving pluripotent stem cells for various purposes, including using human derived beta cells to study diabetes.
Dr. Roger Barker, PhD; Professor, University of Cambridge
Dr. Barker works on the clinical aspects of Parkinson’s and Huntington’s disease, including the study of disease heterogeneity using cognitive testing, functional imaging and genetic biomarkers.